+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urokinase plasminogen activator in human atherosclerotic coronary arteries



Urokinase plasminogen activator in human atherosclerotic coronary arteries



Fibrinolysis 10(Suppl. 3): 3




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144158

Download citation: RISBibTeXText


Related references

Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteries. Thrombosis and Haemostasis 79(3): 579-586, 1998

Expression of urokinase plasminogen activator, its receptor and plasminogen activator inhibitor type 1 in different types of atherosclerotic lesion in human aorta. Tsitologiia 46(4): 352-360, 2004

Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries. Atherosclerosis 145(1): 173-180, 1999

Localization and production of tissue-type plasminogen activator in atherosclerotic human coronary arteries. Annals of Hematology 70(Suppl. 1): A31, 1995

Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions. Blood Coagulation & Fibrinolysis 15(5): 383-391, 2004

Differential effects of acute and chronic wound fluids on urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and tissue-type plasminogen activator in cultured human keratinocytes and fibroblasts. Wound Repair & Regeneration 9(4): 314-322, July-August, 2001

Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants. Cardiovascular Research 36(1): 28-36, 1997

Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants. Cardiovascular Research 36(1): 28-36, 1997

The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 12(2): 82-84, 2004

Tristetraprolin inhibits the growth of human glioma cells through downregulation of urokinase plasminogen activator/urokinase plasminogen activator receptor mRNAs. Molecules and Cells 38(2): 156-162, 2015

Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Stem Cells 26(6): 1406-1413, 2008

Urokinase-type plasminogen activator in human atherosclerotic lesions. Annals of Hematology 70(Suppl. 1): A31, 1995

Gonadotropin surge-induced up-regulation of the plasminogen activators (tissue plasminogen activator and urokinase plasminogen activator) and the urokinase plasminogen activator receptor within bovine periovulatory follicular and luteal tissue. Biology of Reproduction 66(5): 1413-1421, 2002

Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells. Oncology Reports 17(5): 1259-1268, 2007

Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group. American Journal of Cardiology 68(17): 1564-1569, 1991